CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-28 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion | +20,000 | $7.52 | $150K | 40,000 |
| 2019-02-28 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion | +10,000 | $8.03 | $80K | 50,000 |
| 2019-02-28 | BALLIET JENNIFER VP and Chief Culture Officer | Sale | −30,000 | $19.57 | $587K | 20,000 |
| 2019-02-28 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 62,500 | ||
| 2019-02-28 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 40,000 | ||
| 2019-02-28 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +13,986 | $7.15 | $100K | 137,377 |
| 2019-02-28 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −13,986 | 66,666 | ||
| 2019-02-27 | JONES STEVEN C Executive Vice President | Sale | −252,881 | $18.90 | $4.8M | 1,900,000 |
| 2019-02-27 | JONES STEVEN C Executive Vice President | Sale | −32,371 | $18.78 | $608K | 150,000 |
| 2019-02-27 | CARDOZA GEORGE President, Pharma Services | Exercise or conversion | +30,000 | $3.45 | $104K | 244,089 |
| 2019-02-27 | CARDOZA GEORGE President, Pharma Services | Exercise or conversion · Stock Option (Right to Buy) | −30,000 | $3.45 | $104K | 0 |
| 2019-02-27 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −44,135 | $19.23 | $849K | 123,391 |
| 2019-02-26 | JONES STEVEN C Executive Vice President | Sale | −11,721 | $19.24 | $226K | 2,152,881 |
| 2019-02-26 | JONES STEVEN C Executive Vice President | Sale | −1,900 | $19.27 | $37K | 182,371 |
| 2019-02-26 | JONES STEVEN C Executive Vice President | Sale | −1,000 | $19.24 | $19K | 47,657 |
| 2019-02-26 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +119,348 | $7.15 | $853K | 242,739 |
| 2019-02-26 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +66,666 | $7.52 | $501K | 309,405 |
| 2019-02-26 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −141,879 | $18.88 | $2.7M | 167,526 |
| 2019-02-26 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −119,348 | 80,652 | ||
| 2019-02-26 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −66,666 | 133,334 |
Page 41 of 51 · 1,005 trades